Private Equity

Skip to UK content

UK

Gowling WLG's team of private equity experts advises private equity and venture capital investors on a broad range of investments, acquisitions, reorganisations and exits in the mid-market and lower mid-market.

Just like you, we want to get the deal done efficiently and effectively, achieving the desired outcome with minimum fuss. Working closely with our leading sector teams ensures that our clients benefit from lawyers who understand the issues in their industry.

In a 12-month period, we complete more than 20 UK deals on average, with a combined value of over £750 million, across a broad range of sectors including healthcare, software, digital services, financial services and retail.

Working alongside our debt finance, tax, investment funds and structuring specialists, we're able to advise on all aspects of multifaceted transactions. The firm's dedicated Transaction Services team provides due diligence support to ensure that you get the full picture and to improve efficiency on complex and speculative transactions.

From key players in private equity and venture capital to family offices, we're trusted by a diverse range of clients, including August Equity Partners, the Business Growth Fund, Cairngorm Capital, CBPE Capital, Frog Capital, H2 Equity Partners, H.I.G, Livingbridge, LDC, Mobeus Equity Partners, NVM Private Equity, Octopus Investments and SEA Equity.

High-profile work includes advising CBPE on the £186 million disposal of Rosemont Pharmaceuticals (having acted on CBPE's £93 million initial acquisition in 2006) and acting for LDC on the sale of its stake in Kee Safety Group in a £90 million deal with Dunedin.

Highly innovative work includes advising MxP Partners on the deal specific LP funding as well as the more customary acquisition, investment, due diligence and senior and mezzanine banking aspects of the £80 million buyout of Amber Taverns.

Investee companies receive advice on acquisitions, further investments and disposals. The team advised Mountain Warehouse on the buy-out of its stake from LDC, valuing Mountain Warehouse at £85 million. We also act for Equiom on its continuing buy and build programme, supported originally by Livingbridge and now LDC.

We have strong experience acting on both sides of corporate venturing transactions, assisting clients such as Intel and GlaxoSmithKline with acquisitions and investment projects.

Our team delivers an experienced and knowledgeable legal and commercial service to clients, time after time. Understanding the market and what clients need and expect is our definition of great client service.